Prevalence & antimicrobial resistance pattern of extended spectrum β-lactamase producing Klebsiella spp isolated from cases of neonatal septicaemia

Indian Journal of Medical Research

Volumn 125, Issue 1, 2007, Pages 89-94

  Jain, Amita ^a   Mondal, Rajesh ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Extended spectrum lactamase (ESBL); Gram negative septicaemia; Klebsiella spp; Neonatal septicaemia

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; CHLORAMPHENICOL; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TICARCILLIN; TIMENTIN;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; INDIA; INFECTION CONTROL; KLEBSIELLA; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; NONHUMAN; PREVALENCE; RELIABILITY; STRAIN DIFFERENCE; TERTIARY HEALTH CARE;

BACTEREMIA; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; KLEBSIELLA;

EID: 33947159732     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended spectrum beta-lactamase producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 2003; 52 : 421-5.
2. Boo NY, Ng SF, Lim VK. A case control study of risk factors associated with rectal colonization of extended spectrum beta-lactamase producing Klebsiella spp. in newborn infants. J Hosp Infect 2005; 61 : 68-74.
3. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cephotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11 : 315-7.
4. Livermore DM. β-lactamase in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8 : 557-84.
5. Hanberger H, Garcia Rodriguez JA, Gobernado M, Goosens H, Nilsson LE, Strulens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 european countries, French and Portuguese ICU study groups. JAMA 1999; 281 : 67-71.
6. Albertini MT, Benoit C, Berardi L, Berrouane Y, Boisivon A, Cahen P, et al. Surveillance of methicillin resistant Staphylococcus aureus (MRSA) and enterobacteriaceae producing extended spectrum beta-lactamase (ESBLE) in Northern France: a five years multicentre incidence study. J Hosp Infect 2002; 52 : 107-13.
7. Desimoni MC, Esquivel GP, Merino LA. Fecal colonization by extended spectrum beta-lactamase producing Klebsiella pneumoniae in a neonatal intensive care unit. Enferm Infecc Microbiol Clin 2004; 22 : 507-11.
8. Duman M, Abacioglu H, Karaman M, Duman N, Ozkan H. Beta-lactam antibiotic resistance in aerobic commensal fecal flora of newborns. Pediatr Int 2005; 47 : 267-73.
9. Hansotia JB, Agarwal V, Pathak AA, Saoji AM. Extended spectrum beta-lactamase mediate resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Indian J Med Res 1997; 105 : 160-5.
10. Manchanda V, Singh NP, Goyal R, Kumar A, Thukral SS. Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae and evaluation of available techniques for detection of extended spectrum beta-lactamases. Indian J Med Res 2005; 122 : 330-7.
11. Koneman EW Allen SD, Janda WM, Schreckenberger PC, Win WC, editors. The enterobacteriacae. In: Color atlas & textbook of diagnostic microbiology, 5th ed. Philadelphia: JB Lippincott Co.; 1997 p.171-230.
12. Bauer AW, Kirby WMM, Sherris JC, Tuck M. Antibiotics susceptibility testing by standardized single disc method. Am J Clin Pathol. 1966; 45 : 493-6.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 13th Informational Supplement. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards Document M100-S13; 2003.
14. M'Zali FH, Chanawong A, Kerr KG, Birkenhead D, Hawkey PM. Detection of extended spectrum betalactamases in members of the family enterobacteriacae: comparison of the MAST DD test, the double disc and the E test ESBL. J Antimicrob Chemother 2000; 45 : 881-5.
15. Mathai D, Lewis MT, Kugler KC, Pfaller MA, Jones RN. SENTRY Participant Group (North America). Antibacterials activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I-results from the SENTRY antimicrobial surveillance program (North America, 1998). Diagn Microbiol Infect Dis 2001; 32 : 105-16.
16. Saurina G, Quale GM, Manikal VM, Oydna E, Landman D. Antimicrobial resistance in enterobacteriacae in Brooklyn NY: Epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother 2000; 45 : 895-8.
17. Winokur PL, Canton R, Caselass JM, Legakis N. Variations in the prevalence of strains expressing an extended spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the western pacific region. Clin Infect Dis 2001; 32 (Suppl.2): S94-103.
18. Cordero L, Rau R, Taylor D, Avers LW. Enteric gram-negative bacilli bloodstream infections: 17 year's experience in a neonatal intensive care unit. Am J Infect Control 2004; 32 :189-95.
19. Xiong Z, Zzhu D, Zhang Y, Wang F. Extended spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates. Zhonghua Yi Xue Za Zhi 2002; 82 : 1476-9.
20. Goosens H. MYSTIC programme: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis 2001; 41 : 183-9.
21. Tankhiwale SS, Jalgaonkar VS, Ahamad S, Hassani U. Extended spectrum beta-lactamase in urinary isolates. Indian J Med Res 2004; 120 : 553-6.
22. Shubha S, Ananthan S. Extended spectrum beta-lactamase (ESBL) mediated resistance to third genretion cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 2002; 20: 92-5.
23. Shukla I. Prevalence of extended spectrum beta-lactamase in Klebsiealla pneumoniae in a tertiary care hospital. Indian J Med Microbiol 2004; 22 : 87-91.
24. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta-lactamase producing Gram negative bacteria in a tertiary care hospital. Indian J Med Res 2005; 122 : 305-8.
25. Patterson DL, Ko W-C, Gotberg AV, Mohapatra S, Cassels JM, Goosness H, et al. International prospective study of Klebsiealla pneumoniae bacteremia: implications of extended spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140 : 26-32.
26. Gupta E, Mohanty S, Sood S, Dhawan B, Das B, Kapil A. Emerging resistance to carbapenam in a tertiary care hospital in north India. Indian J Med Res 2006; 124 : 95-8.
27. Kurokawa H, Yagi T, Shibta N, Arakawa Y. Worldwide proliferation of carbapenam-resistant gram-negative bacteria. Lancet 1999; 354 : 955.
28. Yano H, Kuga A, Okamoto R, Kitasato H, Koyabashi T, Inone M. Plasmid coded metallo beta-lactamase (imp 6) conferring resistance to carbepenams, especially meropenams. Antimicrob Agents Chemother 2001; 45 : 1343-8.
29. Navneeth BV, Sridaran D, Sahay D, Belwadi MRS. A preliminary study on metallo β-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2002; 116 : 264-7.